Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.0 - $7.24 $7,200 - $10,425
1,440 Added 12.01%
13,430 $69,000
Q1 2024

May 14, 2024

BUY
$6.55 - $9.92 $78,534 - $118,940
11,990 New
11,990 $90,000
Q2 2023

Apr 29, 2024

BUY
$5.78 - $10.02 $69,302 - $120,139
11,990 New
11,990 $82,000
Q1 2023

May 09, 2024

BUY
$6.61 - $10.66 $79,253 - $127,813
11,990 New
11,990 $103 Million
Q1 2022

May 10, 2024

BUY
$13.18 - $26.28 $158,028 - $315,097
11,990 New
11,990 $227,000
Q1 2022

Mar 22, 2023

BUY
$13.18 - $26.28 $56,344 - $112,347
4,275 Added 55.41%
11,990 $227,000
Q1 2022

May 12, 2022

BUY
$13.18 - $26.28 $56,344 - $112,347
4,275 Added 55.41%
11,990 $228,000
Q4 2021

May 17, 2024

BUY
$23.17 - $38.77 $59,546 - $99,638
2,570 Added 49.95%
7,715 $199,000
Q4 2021

Jun 21, 2023

SELL
$23.17 - $38.77 $99,051 - $165,741
-4,275 Reduced 35.65%
7,715 $199,000
Q4 2021

Mar 22, 2023

BUY
$23.17 - $38.77 $59,546 - $99,638
2,570 Added 49.95%
7,715 $199,000
Q4 2021

Feb 15, 2022

BUY
$23.17 - $38.77 $59,546 - $99,638
2,570 Added 49.95%
7,715 $200,000
Q3 2021

May 17, 2024

BUY
$29.99 - $39.13 $43,455 - $56,699
1,449 Added 39.2%
5,145 $167,000
Q3 2021

Jun 21, 2023

SELL
$29.99 - $39.13 $205,281 - $267,844
-6,845 Reduced 57.09%
5,145 $167,000
Q3 2021

Mar 22, 2023

BUY
$29.99 - $39.13 $43,455 - $56,699
1,449 Added 39.2%
5,145 $167,000
Q3 2021

Nov 15, 2021

BUY
$29.99 - $39.13 $154,298 - $201,323
5,145 New
5,145 $167,000
Q2 2021

Aug 16, 2021

SELL
$36.7 - $55.11 $135,643 - $203,686
-3,696 Closed
0 $0
Q1 2021

May 17, 2024

SELL
$39.94 - $75.0 $331,262 - $622,050
-8,294 Reduced 69.17%
3,696 $179,000
Q1 2021

Jun 26, 2023

SELL
$39.94 - $75.0 $331,262 - $622,050
-8,294 Reduced 69.17%
3,696 $179 Million
Q1 2021

Mar 22, 2023

SELL
$39.94 - $75.0 $331,262 - $622,050
-8,294 Reduced 69.17%
3,696 $179,000
Q1 2021

May 14, 2021

BUY
$39.94 - $75.0 $147,618 - $277,200
3,696 New
3,696 $179,000

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $61.3M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.